Companies / BOC Sciences / (Thr2)-Amyloid _-Protein (1-42)
BOC Sciences

(Thr2)-Amyloid _-Protein (1-42) | BOC Sciences

This is a mutation very close to the APP _-secretase cleavage site. The pathogenicity of A_42 Icelandic mutation A2T is lower than the native sequence. The precursor APP A673T is the first variant of APP found to reduce the risk of Alzheimer's disease in humans. A2T also affects the cleavage of _-secretase, and the mutant is an inefficient substrate in a cell-based enzyme assay.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.